Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases
NCT07275580 · Status: NOT_YET_RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 352
Last updated 2026-08-06
Summary
This randomized, double-blind, placebo-controlled clinical trial aims to evaluate whether single-dose amoxicillin prophylaxis administered prior to simple tooth extraction reduces postoperative infection rates inpatients with autoimmune rheumatic diseases (ARDs).
Although antibiotic prophylaxis is not recommended for healthy individuals undergoing simple extractions, immunosuppressed ARD patients frequently receive antibiotics despite limited evidence supporting this practice.
Secondary objectives include assessing infection severity, postoperative complications, and the impact of ARD diagnosis and immunosuppressive treatment on infection risk.
Conditions
- Autoimmune Rheumatic Diseases
- Tooth Extraction
- Infection Prevention
- Antibiotic Prophylaxis
Interventions
- DRUG
-
Amoxicillin
Amoxicillin 2 g a single prophylactic dose prior to simple extraction.
- OTHER
-
Placebo
Matching placebo tablets administered as a single dose prior to extraction
Sponsors & Collaborators
-
Fundação de Amparo à Pesquisa do Estado de São Paulo
collaborator OTHER_GOV -
University of Sao Paulo General Hospital
lead OTHER
Principal Investigators
-
Eloisa Bonfá, Full Professor · Hospital das Clínicas da Faculdade de Medicina da USP - HCFMUSP
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-20
- Primary Completion
- 2029-06-01
- Completion
- 2029-12-30
More Related Trials
-
Local, Non-Interventional Study of RoActemra (Tocilizumab) in Poland (ACT-POL): First-Line Treatment in Routine Clinical Practice of Participants With Rheumatoid Arthritis (RA)
NCT02234960 ·Status: COMPLETED
-
A Study of Tocilizumab in Combination With DMARD Therapy in Patients With Active Rheumatoid Arthritis.
NCT00773461 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults
NCT07235163 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Assess Safety, Tolerability, Pharmacokinetics and Clinical Activity of AMP-110 in Subjects With Rheumatoid Arthritis
NCT02277574 ·Status: COMPLETED ·Phase: PHASE1
-
Duration of Immune Response to Influenza Vaccination in Patients With RA
NCT02311855 ·Status: COMPLETED ·Phase: PHASE4
-
A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid Arthritis
NCT04991753 ·Status: COMPLETED ·Phase: PHASE2
-
A Non-Interventional Study in Patients With Rheumatoid Arthritis Who Are Treated With RoActemra/Actemra (Tocilizumab)
NCT01893255 ·Status: WITHDRAWN
-
Safety and Immunogenicity of PCV20 in Pediatric Patients With Autoimmune Rheumatic Diseases
NCT07252791 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs
NCT01034397 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
NCT05489224 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Safety and Efficacy of Modified-Release Prednisone (Lodotra®) Therapy in Patients With Active Rheumatoid Arthritis
NCT00650078 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of SMS Reminders on Influenza Vaccination Coverage in Patients With RA in the ART Registry
NCT05220423 ·Status: COMPLETED ·Phase: NA
-
Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases
NCT07341386 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of the Effects of RoActemra/Actemra (Tocilizumab) on Neutrophils in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic and/or Non-biologic DMARDs.
NCT01195272 ·Status: COMPLETED ·Phase: PHASE4
-
Tocilizumab Effect iN pOlymyalgia Rheumatica
NCT01713842 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis
NCT00777816 ·Status: SUSPENDED ·Phase: PHASE2
-
A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDs
NCT02720523 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Assess the Effect of Tocilizumab + Methotrexate on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT00106548 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) Given Subcutaneously in Combination With Traditional DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01232569 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter, Post-marketing, Non-interventional, Observational Study in RA Patients Treated With RoActemra/Actemra (Tocilizumab)
NCT02101307 ·Status: COMPLETED
-
Assessment of the Effect of Adalimumab on Response to Influenza Virus and Pneumococcal Vaccines in Subjects With Rheumatoid Arthritis
NCT00649922 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis
NCT01951170 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Immune Response Following Zoster Vaccination to Subjects With Rheumatoid Arthritis Receiving Tofacitinib or Placebo With Background Methotrexate
NCT02147587 ·Status: COMPLETED ·Phase: PHASE2
-
Lymphocyte and Cytokine Disturbances in Polymyalgia Rheumatica
NCT02888496 ·Status: COMPLETED
-
Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)
NCT00542022 ·Status: COMPLETED ·Phase: PHASE2